Arkolith/Insider Trading/AKTS/Form 4

Ron-Bigger Shulamit

Chief Operating OfficerAktis Oncology, Inc. (AKTS) · full profile →Form 4 · filed Jul 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 8, 2026Option exercise(M)50K$3.66$183K50K
Jul 8, 2026Sell(S)16K$27.13$429K34K
Jul 8, 2026Sell(S)30K$27.94$838K4K
Jul 8, 2026Sell(S)4K$28.75$121K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 8, 2026Option exercise(M)50K—$0218K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-300163) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML